| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $982.0M | +32.9% |
| Cost of Revenue | $349.0M | +20.4% |
| R&D Expense | $364.2M | +4.7% |
| SG&A Expense | $211.4M | +17.4% |
| Operating Income | -$437.2M | +1.4% |
| Interest Expense | $3.9M | +51.0% |
| Pre-tax Income | -$417.5M | +4.0% |
| Income Tax | -$1.3M | -198.4% |
| Net Income | -$416.3M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $378.2M | -28.0% |
| Accounts Receivable | $137.8M | +25.0% |
| Inventory | $85.9M | +20.8% |
| Current Assets | $1.47B | +38.9% |
| Total Assets | $2.01B | +35.5% |
| Current Liabilities | $302.7M | +34.2% |
| Long-term Debt | $1.50B | +31.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$184.8M | +23.0% |
| Capital Expenditures | $48.3M | +37.7% |
| Investing Cash Flow | -$627.2M | -140.0% |
| Financing Cash Flow | $671.1M | — |
| Free Cash Flow | -$233.1M | +15.2% |
| +4.6% |
| EPS (Basic) | -$3.32 | +6.7% |
| EPS (Diluted) | -$3.32 | +6.7% |
| Total Liabilities |
| $2.11B |
| +30.0% |
| Stockholders' Equity | -$99.3M | +28.9% |